Main Session
Sep
29
PQA 03 - Central Nervous System, Professional Development/Medical Education
2651 - Outcomes for Patients with High-Risk IDH-Mutant Grade 2 Gliomas Treated with IDH Inhibitors
Presenter(s)
Jane Pearce, MD - MD Anderson Cancer Center, Houston, TX